trending Market Intelligence /marketintelligence/en/news-insights/trending/nkB6rKTe_LMHAoVtr8d0rg2 content esgSubNav
In This List

Spark Therapeutics prices common stock offering

Blog

Post-webinar Q&A: Global Credit Risk Trends 2021 and Beyond

Blog

University Essentials: From Crisis to Resilience – Navigating Sustainable Recovery

Blog

EV impact; vaccines to boost job market; coal supply constraints

Blog

Shore Capital is Now Available in S&P Global’s Aftermarket Research Collection


Spark Therapeutics prices common stock offering

Spark Therapeutics Inc. priced an offering of 4,605,264 common shares at $76 apiece for expected net proceeds of about $330.8 million.

The company also granted underwriters an option to buy up to 690,789 additional shares.

The offering is expected to close by Aug. 9, subject to customary closing conditions.

J.P. Morgan Securities LLC, Goldman Sachs & Co. LLC and Cowen and Co. LLC are acting as book-running managers for the offering.